Moderna Seeks FDA Vax Approval For Children Under 6

NPR reports:

Moderna is hoping to get the green light to administer a pediatric, low-dose COVID-19 vaccine for children ages 6 months to under 6 years of age, it said in a statement.

The pharmaceutical company will submit a request to the Food and Drug Administration “in the coming weeks” for authorization for a two-dose, 25 microgram-each shot. That’s 25% of the first two doses adults received, the company said.

“Given the need for a vaccine against COVID-19 in infants and young children, we are working with the U.S. FDA and regulators globally to submit these data as soon as possible,” Moderna CEO Stéphane Bancel said in the statement.

Read the full article.

JUST IN: Moderna will seek FDA emergency authorization for its COVID vaccine for children under 6 in the coming weeks, the company said, after tests of the low-dose shots showed a strong immune response.https://t.co/xtiwGEcrR2

— NPR (@NPR) March 23, 2022